Press Releases/What’s New

The City of Portsmouth has authorized the NH Department of Environmental Services (NHDES) to place temporary air quality monitoring devices in locations surrounding the Foundry Place Garage. The air quality study was authorized by NHDES in response to City concerns regarding air quality complaints from the neighborhood and residents’ reports of emissions from locomotives in the railyard.

The Foundation for Seacoast Health has announced their intent to sell the Community Campus building and surrounding 34 acres to the City of Portsmouth. Following a three-year strategic planning process and a goal to maintain its original vision as a multi-tenant non-profit center, while adding new resources to benefit the community, the Foundation has determined the City to be the ideal buyer to manage the Campus.

What is the “Evusheld” treatment and how does it work?

Evusheld is a pre-COVID protection option developed by AstraZeneca that combines two monoclonal antibodies (tixagevimab and cilgavimab) in one injection. In a study of persons who were at high risk of severe illness, hospitalization, or death from COVID-19 because they were immunocompromised or ineligible to receive a COVID-19 vaccination, Evusheld was shown to reduce the risk of developing COVID-19 compared to those who received a placebo.

Portsmouth DPW is launching an online survey to collect feedback from residents and business/property owners as to what they would like to see in the sidewalk and roadway reconstruction plan for the Fleet Street Area Reconstruction Project.